Loading clinical trials...
Loading clinical trials...
EGFR Tyrosine-Kinase Inhibitor monotherapy is widely used in treatment of patients with EGFR mutation-positive Non-small cell lung cancer(NSCLC), In despite of the benefit of PFS （progression-free sur...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Zaiwen Fan
NCT06813079 · Pancreatic Ductal Carcinoma, Advanced Cancer, and more
NCT05076760 · Solid Tumor, Advanced Cancer, and more
NCT06616298 · Advanced Cancer
NCT06426511 · Lung Cancer, Nonsmall Cell
NCT07260708 · Advanced Cancers
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions